June 25, 2026
3 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
Trends in the identification and treatment of ALS are expected to lead to a significant increase in clinic demand over the next decade, highlighting the need for greater investment, according to a study published in Neurology Genetics. No prior study has estimated the number of gene-positive symptomatic and asymptomatic individuals or translated those estimates into projected clinic visits,
June 25, 2026
3 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

Genetic screening in the wake of new therapies will identify more at-risk relatives

CHICAGO — In this video, Mitchell Singstock, MD, discusses results of a retrospective study that evaluated genomic testing rates…

We are living in an exciting new era for Alzheimer’s treatment. For the first time, therapies can slow the disease for some…

Updates About the Expanded Access Program for MN-166 in ALS

Glint of light in therapy for deadly ALS after decades of struggle New drug shows researchers ‘this illness can be stopped’

The expanded definition of autism spectrum disorder, increased use of screening tools and well visit recommendations from the…